Compare BSTZ & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSTZ | IRMD |
|---|---|---|
| Founded | 2019 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2014 |
| Metric | BSTZ | IRMD |
|---|---|---|
| Price | $30.29 | $91.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $116.00 |
| AVG Volume (30 Days) | ★ 214.7K | 110.5K |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | ★ 8.31% | 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ 0.71 | 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $12.38 |
| Revenue Next Year | N/A | $11.31 |
| P/E Ratio | ★ $42.70 | $205.44 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $19.13 | $55.11 |
| 52 Week High | $30.46 | $107.90 |
| Indicator | BSTZ | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.61 | 52.79 |
| Support Level | $21.00 | $82.87 |
| Resistance Level | N/A | $98.31 |
| Average True Range (ATR) | 0.77 | 3.10 |
| MACD | 0.12 | 0.85 |
| Stochastic Oscillator | 92.01 | 62.25 |
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.